Can someone share their thoughts on the Monepantel tablets- previously on these threads people have said that 75k tabs are ready and paid for so funds wouldn’t be needed for it. Now in the Ann they say part of the funds will be used for GMP manufacturing of the tablets.
1. Is the 75k tabs previously manufactured a waste or they additional tabs because we plan to do phase 2 and 3 jointly instead of only phase 2 they had previously catered for?
2. If they are specifically calling out GMP manufactured tabs, were the previous batch not GMP quality?
3. If we are only kicking of the tab manufacturing now, will we be in time for the trials to kick off? Continuing from Q1, if we had enough tabs for phase 2 then that could start and we produce more tabs for phase 3.
Thanks.
Can someone share their thoughts on the Monepantel tablets-...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |